Biodegradable Polymers for Emerging Clinical Use in Tissue Engineering

Biodegradable Polymers in Clinical Use and Clinical Development

Volumn , Issue , 2011, Pages 565-629

  Verma, Shalini ^a   Garkhal, Kalpna ^a   Mittal, Anupama ^a   Kumar, Neeraj ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Biodegradable polymers for clinical use in tissue engineering natural and synthetic origin in biomedical applications; Need specific polymeric biomaterials and field of stem cell technology, in regenerative medicine; Tissue engineering, new in multidisciplinary research revolutionizing treatment, diseased and damaged tissues or organs

Indexed keywords

EID: 84886559336     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118015810.ch16     Document Type: Chapter

References (247)

1. Anonymous. Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1997-2006 ed., Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation: Rockville, MD; 2007.
2. Griffith, L. G. and G. Naughton. Tissue engineering-current challenges and expanding opportunities. Science 2002;295(5557):1009-1014.
3. Wang, M. Materials selection and scaffold fabrication for tissue engineering in orthopaedics. In Advanced Bioimaging Technologies in Assessment of the Quality of Bone and Scaffold Materials. L. Qin, H. K. Genant, J. F. Griffith, and K. S. Leung..(eds.) Springer: New York, 2007. pp. 259-288.
4. Flanagan, T. C. and A. Pandit. Living artificial heart valve alternatives: A review. Eur. Cell Mater. 2003;6:28-45.
5. Stock, U. A. and K. Schenke-Layland. Performance of decellularized xenogeneic tissue in heart valve replacement. Biomaterials 2006;27(1):1-2.
6. Forrester, J. S., M. J. Price, and R. R. Makkar. Stem cell repair of infarcted myocardium: An overview for clinicians. Circulation 2003;108(9):1139-1145.
7. Tabata, Y. Significant role of cell scaffolding and DDS technology in tissue regeneration: Tissue engineering strategies. Int. Cong. Ser. 2005;1284:257-265.
8. Dang, J. M. and K. W. Leong. Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 2006;58(4):487-499.
9. Krebs, N. Advances in cardiac tissue engineering and cardiac tissue replacement modalities. J. Undergrad. Res. 2003;2(1):41-45.
10. Nair, L. S. and C. T. Laurencin. Biodegradable polymers as biomaterials. Prog. Polym. Sci. 2007;32(8-9):762-798.
11. Gunatillake, P. A. and R. Adhikari. Biodegradable synthetic polymers for tissue engineering. Eur. Cell Mater. 2003;5:1-16.
12. Pillai, O. and R. Panchagnula. Polymers in drug delivery. Curr. Opin. Chem. Biol. 2001;5(4):447-451.
13. Gilbert, T. W., A. M. Stewart-Akers, and S. F. Badylak. A quantitative method for evaluating the degradation of biologic scaffold materials. Biomaterials 2007;28(2): 147-150.
14. Chung, H. J. and T. G. Park. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv. Drug Deliv. Rev. 2007;59(4-5):249-262.
15. Sung, H. J., C. Meredith, C. Johnson, and Z. S. Galis. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 2004;25(26):5735-5742.
16. Park, H., J. S. Temenoff, and A. G. Mikos. Biodegradable orthopedic implants. In F. Bronner, M. C. Farach-Carson, and A. G. Mikos(Eds.). Engineering of Functional Skeletal Tissues, Springer: London, 2007.
17. Chandra, R. and R. Rustgi. Biodegradable polymers. Prog. Polym. Sci. 1998;23(7): 1273-1335.
18. Garkhal, K., S. Verma, S. Jonnalagadda, and N. Kumar. Fast degradable poly(L-lactide-co-caprolactone) microspheres for tissue engineering: Synthesis, characterization, and degradation behavior. J. Polym. Sci.: Part A: Polym. Chem. 2007;45: 2755-2764.
19. Chen, D., H. Chen, J. Bei, and S. Wang. Morphology and biodegradation of microspheres of polyester-polyether block copolymer based on polycaprolactone/ polylactide/poly(ethylene oxide). Polym. Int. 2000;49:269-276.
20. Dong, C. M., Y Z. Guo, K. Y. Qiu, Z. W. Gu, and X. D. Feng. In vitro degradation and controlled release behavior of D,L-PLGA50 and PCL-B-D,L-PLGA50 copolymer microspheres. J. Control. Release 2005;107(1):53-64.
21. Grayson, A. C., M. J. Cima, and R. Langer. Size and temperature effects on poly(lactic-co-glycolic acid) degradation and microreservoir device performance. Biomaterials 2005;26(14):2137-2145.
22. Mittal, A., P. Negi, K. Garkhal, S. Verma, and N. Kumar. Integration of porosity and biofunctionalization to form 3D scaffold: Cell culture studies and in vitro degradation. Biomed. Mater. 2010;5(4):045001.
23. Cao, Y., G. Mitchell, A. Messina, L. Price, E. Thompson, A. Penington, W. Morrison, A. O'Connor, G. Stevens, and J. Cooper-White. The influence of architecture on degradation and tissue ingrowth into three-dimensional poly(lacticco- glycolic acid) scaffolds in vitro and in vivo. Biomaterials 2006;27(14):2854-2864.
24. Wu, L. and J. Ding. In vitro degradation of three-dimensional porous poly(D,L-lactideco- glycolide) scaffolds for tissue engineering. Biomaterials 2004;25(27):5821-5830.
25. Verma, S. and N. Kumar. Effect of biomimetic 3D environment and degradation behavior of injectable bone filler: An in vitro evaluation. Mater. Sci. Eng: C 2010;30(8):1118-1128.
26. Mikos, A. G., L. V. McIntire, J. M. Anderson, and J. E. Babensee. Host response to tissue engineered devices. Adv. Drug Deliv. Rev. 1998;33(1-2):111-139.
27. Schliecker, G., C. Schmidt, S. Fuchs, and T. Kissel. Characterization and in vitro degradation of poly(2,3-(1,4-diethyl tartrate)-co-2,3-isopropyliden tartrate). J. Control. Release 2004;98(1):11-23.
28. ISO. Biological Evaluation of Medical Devices-Part 1: Evaluation and Testing. International Organization for Standardization: Geneva, 1997.
29. Northup, S. J. Safety evaluation of medical devices: U.S. Food and Drug Administration and International Standards Organization Guidelines. Int. J. Toxicol. 1999;18(4):275-283.
30. Lutolf, M. P. and J. A. Hubbell. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnol. 2005;23(1):47-55.
31. Garkhal, K., A. Mittal, S. Verma, and N. Kumar. P-15 functionalized porous microspheres as biomimetic habitats for bone tissue engineering applications. Polym. Adv. Technol. 2011;22(1):190-198.
32. Pegueroles, M., C. Aparicio, M. Bosio, E. Engel, F. J. Gil, J. A. Planell, and G. Altankov. Spatial organization of osteoblast fibronectin matrix on titanium surfaces: Effects of roughness, chemical heterogeneity and surface energy. Acta Biomater. 2010;6(1):291-301.
33. Neiva, R. F., Y. P. Tsao, R. Eber, J. Shotwell, E. Billy, and H.-L. Wang. Effects of a putty-form hydroxyapatite matrix combined with the synthetic cell-binding peptide P-15 on alveolar ridge preservation. J. Periodontol. 2008;79:291-299.
34. Milburn, C., J. Chen, Y. Cao, G. M. Oparinde, M. O. Adeoye, A. Beye, and W. O. Soboyejo. Investigation of effects of argentine-glycine-aspartate(RGD) and nano-scale titanium coatings on cell spreading and adhesion. Mater. Sci. Eng.: C 2009;29(1):306-314.
35. Andukuri, A., W. P. Minor, M. Kushwaha, J. M. Anderson, and H. W. Jun. Effect of endothelium mimicking self-assembled nanomatrices on cell adhesion and spreading of human endothelial cells and smooth muscle cells. Nanomedicine 2010;6(2): 289-297.
36. Shin, H., S. Jo, and A. G. Mikos. Biomimetic materials for tissue engineering. Biomaterials 2003;24(24):4353-4364.
37. Gadegaard, N., E. Martines, M. O. Riehle, K. Seunarine, and C. D. W. Wilkinson. Applications of nano-patterning to tissue engineering. Microelect. Eng. 2006;83(4-9):1577-1581.
38. Charulatha, V. and A. Rajaram. Influence of different crosslinking treatments on the physical properties of collagen membranes. Biomaterials 2003;24(5):759-767.
39. Hennink, W. E. and C. F. V. Nostrum. Novel crosslinking methods to design hydrogels. Adv. Drug Deliv. Rev. 2002;54(1):13-36.
40. Elvin, C. M., A. G. Brownlee, M. G. Huson, T. A. Tebb, M. Kim, R. E. Lyons, T. Vuocolo, N. E. Liyou, T. C. Hughes, J.A.M. Ramshaw, and J. A. Werkmeiste. The development of photochemically crosslinked native fibrinogen as a rapidly formed and mechanically strong surgical tissue sealant. Biomaterials 2009;30(11):2059-2065.
41. Tessmar, J. K. and A. M. Gopferich. Matrices and scaffolds for protein delivery in tissue engineering. Adv. Drug Deliv. Rev. 2007;59(4-5):274-291.
42. Kohn, J. New approaches to biomaterials design. Nature Mater. 2004;3(11): 745-747.
43. Yu, L., K. Dean, and L. Li. Polymer blends and composites from renewable resources. Prog. Polym. Sci. 2006;31:576-602.
44. Malafaya, P. B., G. A. Silva, and R. L. Reis. Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv. Drug Deliv. Rev. 2007;59:207-233.
45. Gelinsky, M., P. B. Welzel, P. Simon, A. Bernhardt, and U. König. Porous threedimensional scaffolds made of mineralised collagen: Preparation and properties of a biomimetic nanocomposite material for tissue engineering of bone. Chem. Eng. J. 2008;137:84-96.
46. Thornton, J. F. and R. J. Rohrich. Dermal substitute(Integra) for open nasal wounds. Plastic Reconst. Surg. 2005;116:677.
47. Wu, W., X. Feng, T. Mao, X. Feng, H. W. Ouyang, G. Zhao, and F. Chen. Engineering of human tracheal tissue with collagen-enforced poly-lactic-glycolic acid non-woven mesh: A preliminary study in nude mice. Br. J. Oral Maxillofac. Surg. 2007;45:272-278.
48. Dai, W., N. Kawazoe, X. Lin, J. Dong, and G. Chen. The influence of structural design of PLGA/collagen hybrid scaffolds in cartilage tissue engineering. Biomaterials 2010;31(8):2141-2152.
49. Narotham, P. K., S. Jose, N. Nathoo, C. Taylon, and Y. Vora. Collagen matrix(DuraGen) in dural repair: Analysis of a new modified technique. Spine 2004;29:2861-2867.
50. Duan, X., C. McLaughlin, M. Griffith, and H. Sheardown. Biofunctionalization of collagen for improved biological response: Scaffolds for corneal tissue engineering. Biomaterials 2007;28:78-88.
51. Holland, T. A., J. K. V. Tessmar, Y. Tabata, and A. G. Mikos. Transforming growth factor-beta1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J. Control. Release. 2004;94:101-114.
52. Holland, T. A., Y. Tabata, and A. G. Mikos. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J. Control. Release 2005;101(1-3):111-125.
53. Park, H., J. S. Temenoff, T. A. Holland, Y. Tabata, and A. G. Mikos. Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 2005;26:7095-7103.
54. Okamoto, T., Y. Yamamoto, M. Gotoh, C. L. Huang, T. Nakamura, Y. Shimizu, T. Tabata, and H. Yokomise. Slow release of bone morphogenetic protein 2 from a gelatin sponge to promote regeneration of tracheal cartilage in a canine model. J. Thorac. Cardiovasc. Surg. 2004;127:329-334.
55. Kimura, Y., M. Ozeki, T. Inamoto, and Y. Tabata. Adipose tissue engineering based on human preadipocytes combined with gelatin microspheres containing basic fibroblast growth factor. Biomaterials 2003;24:2513-2521.
56. Payne, R. G., M. J. Yaszemski, A. W. Yasko, and A. G. Mikos. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. Biomaterials 2002;23:4359-4371.
57. Payne, R. G., J. S. McGonigle, M. J. Yaszemski, A.W. Yasko, and A. G. Mikos. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 2. Viability of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate). Biomaterials 2002;23:4373-4380.
58. Liu, Y. and M. B. Chan-Park. A biomimetic hydrogel based on methacrylated dextran-graft-lysine and gelatin for 3D smooth muscle cell culture. Biomaterials 2010;31(6):1158-1170.
59. Awad, H. A., M. O. Wickham, H. Leddy, J. M. Gimble, and F. Guilak. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials 2004;25:3211-3222.
60. Ponticiello, M. S., R. M. Schinagl, S. Kadiyala, and F. P. Barry. Gelatin-based resorbable sponge as a carrier matrix for human mesenchymal stem cells in cartilage regeneration therapy. J. Biomed. Mater. Res. 2000;52:246-255.
61. Malda, J., E. Kreijveld, J. S. Temenoff, C. A. Van Blitterswijk, and J. Riesle. Expansion of human nasal chondrocytes on macroporous microcarriers enhances redifferentiation. Biomaterials 2003;24:5153-5161.
62. Liu, X., L. A. Smith, J. Hu, and P. X. Maa. Biomimetic nanofibrous gelatin/apatite composite scaffolds for bone tissue engineering. Biomaterials 2009;30:2252-2258.
63. Ghasemi-Mobarakeh, L., M. P. Prabhakarana, M. Morshed, M. H. Nasr-Esfahani, and S. Ramakrishna. Electrospun poly(e-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering. Biomaterials 2008;29(34):4532-4539.
64. Ahmed, T. A., E. V. Dare, and M. Hincke. Fibrin: A versatile scaffold for tissue engineering applications. Tissue Eng. Part B 2008;14(2):199-215.
65. Wechselberger, G., R. Russell, M. Neumeister, T. Schoeller, H. Piza-Katzer, and C. Rainer. Successful transplantation of three tissue-engineered cell types using capsule induction technique and fibrin glue as a delivery vehicle. Plastic Reconst. Surg. 2002;110:123-129.
66. Wechselberger, G., T. Schoeller, A. Stenzl, M. Ninkovic, S. Lille, and R. C. Russell. Fibrin glue as a delivery vehicle for autologous urothelial cell transplantation onto a prefabricated pouch. J. Urol. 1998;160(2):583-586.
67. Rainer, C., G. Wechselberger, T. Bauer, M. W. Neumeister, S. Lille, A. Mowlavi, H. Piza, and T. Schoeller. Transplantation of tracheal epithelial cells onto a prefabricated capsule pouch with fibrin glue as a delivery vehicle. J. Thor. Cardiovas. Surg. 2001;121(6):1187-1193.
68. Willerth, S. M., K. J. Arendas, D. I. Gottlieb, and S. E. Sakiyama-Elbert. Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials 2006;27:5990-6003.
69. Schantz, J. T., A. Brandwood, D. Hutmacher, H. Khor, and K. Bittner. Osteogenic differentiation of mesenchymal progenitor cells in computer designed fibrinpolymer- ceramic scaffolds manufactured by fused deposition modeling. J. Mater. Sci. Mater. Med. 2005;16:807-819.
70. Eyrich, D., F. Brandl, B. Appel, H. Wiese, G. Maier, M. Wenzel, R. Staudenmaier, A. Goepferich, and T. Blunk. Long-term stable fibrin gels for cartilage engineering. Biomaterials 2007;28:55-65.
71. Ho, S. T. B., S. M. Cool, J. H. Hui, and D. W. Hutmacher. The influence of fibrin based hydrogels on the chondrogenic differentiation of human bone marrow stromal cells. Biomaterials 2010;31:38-47.
72. Altman, G. H., F. Diaz, C. Jakuba, T. Calabro, R. Horan, J. Chen, H. Lu, J. Richmond, and D. L. Kaplan. Silk-based biomaterials. Biomaterials. 2003;24: 401-416.
73. Hinman, M. B., J. A. Jones, and R. V. Lewis. Synthetic spider silk: A modular fiber. Trends Biotechnol. 2000;18:374-379.
74. Tamada, Y. New process to form a silk fibroin porous 3-D structure. Biomacromolecules 2005;6:3100-3106.
75. Pra, I. D., G. Freddi, J. Minic, and U. Armato. De novo engineering of reitcular connective tissue in vivo by silk fibroin nonwoven materials. Biomaterials 2005;26:1987-1999.
76. Horan, R. L., K. Antle, A. L. Collette, Y. Wang, J. Huang, and J. E. Moreau. In vitro degradation of silk fibroin. Biomaterials 2005;26:3385-3393.
77. Hofmann, S., C. Foo, F. Rossetti, M. Textor, G. Vunjak-Novakovic, D. L. Kaplan, H. P. Merkle, and L. Meinel. Silk fibroin as an organic polymer for controlled drug delivery. J. Control. Release 2006;111:219-227.
78. Sofia, S., M. B. MacCarthy, G. Gronowiz, and D. L. Kaplan. Functionalized silk based biomaterials. J. Biomed. Mater. Res. 2001;54:139-148.
79. Hino, R., M. Tomito, and K. Yoshizato. The generation of germline transgenic silkworms for the production of biologically active recombinant fusion proteins of fibroin and human basic fibroblast growth factor. Biomaterials 2006;27:5715-5724.
80. Mandal, B. B., and S. C. Kundu. Cell proliferation and migration in silk fibroin 3D scaffolds. Biomaterials 2009;30(15):2956-2965.
81. Fang, Q., D. Chen, Z. Yang, and M. Li. In vitro and in vivo research on using Antheraea pernyi silk fibroin as tissue engineering tendon scaffolds. Mater. Sci. Eng.: C 2009;1527-1534.
82. Patel, A., B. Fine, M. Sandig, and K. Mequanint. Elastin biosynthesis: The missing link in tissue-engineered blood vessels. Cardiovasc. Res. 2006;71:40-49.
83. Mithieux, S. M., and J. E. J. Rasko, and A. S. Weiss. Synthetic elastin hydrogels derived from massive elastic assemblies of selforganized human protein monomers. Biomaterials 2004;25:4921-4927.
84. Woodhouse, K. A., P. Klement, V. Chen, M. B. Gorbet, and F. W. Keeley. Investigation of recombinant human elastin polypeptides as non-thrombogenic coatings. Biomaterials 2004;25:4543-4553.
85. Nivison-Smith, L., J. Rnjak, and A. S. Weiss. Synthetic human elastin microfibers: Stable cross-linked tropoelastin and cell interactive constructs for tissue engineering applications. Acta Biomater. 2010;6:354-359.
86. Betre, H., S. R. Ong, F. Guilak, A. Chilkoti, B. Fermor, and L. A. Setton. Chondrocytic differentiation of human adipose derived adult stem cells in elastinlike polypeptide. Biomaterials 2006;27:91-99.
87. Silva, S. S., J. M. Oliveira, J. A. Mano, and R. L. Reis. Physicochemical characterization of novel chitosan-soy protein/TEOS porous hybrids for tissue engineering applications. Mater. Sci. Forum 2006;1000-1004.
88. Vaz, C. M., P. F. Doeveren, R. L. Reis, and A. M. Cunha. Development and design of double-layer co-injection moulded soy protein based drug delivery devices. Polymer 2003;44:5983-5992.
89. Vaz, C. M., P. F. V. Doeveren, R. L. Reis, and A. M. Cunha. Soy matrix drug delivery systems obtained by melt-processing techniques. Biomacromolecules, 2003;1520-1529.
90. Vaz, C. M., M. Fossen, R. F. V. Tuil, L. A. D. Graaf, R. L. Reis, and A. M. Cunha. Casein and soybean protein-based thermoplastics and composites as alternative biodegradable polymers for biomedical applications. J. Biomed. Mater. Res. 2003;65A:60-70.
91. Khor, E., and L. Y. Lim. Implantable applications of chitin and chitosan. Biomaterials 2003;24:2339-2349.
92. George, M., and T. E. Abraham. Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan-a review. J. Control. Release 2006;114:1-14.
93. Martino, A. D., M. Sittinger, and M. V. Risbud. Chitosan: A versatile biopolymer for orthopaedic tissue-engineering. Biomaterials 2005;26:5983-5990.
94. Lee, J. Y., S. H. Nam, S. Y. Im, Y. J. Park, Y. M. Lee, Y. J. Seol, C. P. Chung, and S. J. Lee. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomatetials. J. Control. Release 2002;78:187-197.
95. Okamoto, Y., R. Yano, K. Miyatake, I. Tomohiro, Y. Shigemasa, and S. Minami. Effects of chitin and chitosan on blood coagulation. Carbohydr. Polym. 2003;53:337-342.
96. Kweon, D. K., S. B. Song, and Y. Y. Park. Preparation of water-soluble chitosan/ heparin complex and its application as wound healing accelerator. Biomaterials 2003;24:1595-1601.
97. Ueno, H., T. Mori, and T. Fujinaga. Topical formulations and wound healing applications of chitosan. Adv. Drug Deliv. Rev. 2001;52:105-115.
98. Jayakumar, R., M. Prabaharan, S. V. Nair, and H. Tamura. Novel chitin and chitosan nanofibers in biomedical applications. Biotech. Adv. 2010;28:142-150.
99. Kim, I., S. Seo, H. Moon, M. Yoo, I. Park, B. Kim, and C. Cho. Chitosan and its derivatives for tissue engineering applications. Biotech. Adv. 2008;26:1-21.
100. Tan, H., C. R. Chu, K. A. Payne, and K. G. Marra. Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering. Biomaterials 2009;30(13):2499-2506.
101. Basmanav, F. B., G. J. Koseb, and V. Hasirci. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. Biomaterials 2008;29:4195-4204.
102. Moya, M. L., M. H. Cheng, J. Huang, M. E. Francis-Sedlak, S. I. Kao, E. C. Opara, and E. M. Brey. The effect of FGF-1 loaded alginate microbeads on neovascularization and adipogenesis in a vascular pedicle model of adipose tissue engineering. Biomaterials 2010;31(10):2816-2826.
103. Liao, Y. H., S. A. Jones, B. Forbes, G. P. Martin, and M. B. Brown. Hyaluronan: Pharmaceutical characterization and drug delivery. Drug Deliv. 2005;12: 327-342.
104. Laurent, T. C., U. B. G. Laurent, and J. R. E. Fraser. Functions of hyaluronan. Ann. Rheum. Dis. 1995;54: 429-432.
105. Lee, C. T., P. H. Kung, and Y. D. Lee. Preparation of poly(vinyl alcohol)- chondroitin sulfate hydrogel as matrices in tissue engineering. Carbohydr. Polym. 2005;61:348-354.
106. Chang, K.-Y., L.-W. Cheng, G. H. Ho, Y.-P. Huang, and Y.-D. Lee. Fabrication and characterization of poly(β-glutamic acid)-graft-chondroitin sulfate/polycaprolactone porous scaffolds for cartilage tissue engineering. Acta Biomater. 2009;5(6):1937-1947.
107. Bassleer, C. T., J. P. A. Combal, S. Bougaret, and M. Malaise. Effects of chondroitin sulfate and interleukin-1β on human articular chondrocytes cultivated in clusters. Osteoarthr. Cartil. 1998;6:196-204.
108. Galtrey, C. M., and J. W. Fawcett. The role of chondroitin sulfate proteoglycans in regeneration and plasticity in the central nervous system. Brain Res. Rev. 2007;54:1-18.
109. Lee, J., M. J. Cuddihy, and N. A. Kotov. Three-dimensional cell culture matrices: State of the art. Tissue Eng.: Part B 2008;14(1):61-86.
110. Poutanen, K. and P. Forssell. Modification of starch properties with plasticizers. Trends Polym. Sci. 1996;4:128-132.
111. Reis, R. L., and A. M. Cunha. Characterization of two biodegradable polymers of potential application within the biomaterials field. J. Mater. Sci. Mater. Med. 1995;6:786-792.
112. Gomes, M. E., A. S. Ribeiro, P. B. Malafaya, R. L. Reis, and A. M. Cunha. A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: Morphology, mechanical and degradation behaviour. Biomaterials 2001;22:883-889.
113. Gomes, M. E., J. S. Godinho, D. Tchalamov, A. M. Cunha, and R. L. Reis. Alternative tissue engineering scaffolds based on starch: Processing methodologies, morphology, degradation and mechanical properties. Mater. Sci. Eng. 2002;20:19-26.
114. Espigares, I., C. Elvira, J. E. Mano, B. Vazquez, J. S. Roman, and R. L. Reis. New partially degradable and bioactive acrylic bone cements based on starch blends and ceramic fillers. Biomaterials 2002;23:1883-1895.
115. Boesel, L. F., and R. L. Reis. The effect of water uptake on the behaviour of hydrophilic cements in confined environments. Biomaterials 2006;27:5627-5633.
116. Silva, G. A., F. J. Costa, N. M. Neves, O. P. Coutinho, A. C. P. Dias, and R. L. Reis. Entrapment ability and release profile of corticosteroids from starch-based particles. J. Biomed. Mater. Res. 2005;73:234-243.
117. Malafaya, P. B., F. Stappers, and R. L. Reis. Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers. J. Mater. Sci.: Mater. Med. 2006;17:371-377.
118. Ghosh, S., J. C. Viana, R. L. Reis, and J. F. Mano. Bi-layered constructs based on poly(L-lactic acid) and starch for tissue engineering of osteochondral defects. Mater. Sci. Eng.: C 2008;28(1):80-86.
119. Balmayor, E. R., K. Tuzlakoglu, H. S. Azevedo, and R. L. Reis. Preparation and characterization of starch-poly-e-caprolactone microparticles incorporatingbioactive agents for drug delivery and tissue engineering applications. Acta Biomater. 2009;5(4):1035-1045.
120. Ye, C., P. Hu, M. Ma, Y. Xiang, R. Liu, and X. Shang. PHB/PHBHHx scaffolds and human adipose-derived stem cells for cartilage tissue engineering. Biomaterials 2009;30(26):4401-4406.
121. Misra, S. K., T. I. Ansari, S. P. Valappil, D. Mohn, S. E. Philip, W. J. Stark, I. Roy, J. C. Knowles, V. Salih, and A. R. Boccaccini. Poly(3-hydroxybutyrate) multifunctional composite scaffolds for tissue engineering applications. Biomaterials 2010;31(10):2806-2915.
122. Wang, L., N. H. Dormer, L. Bonewald, and M. S. Detamore. Osteogenic differentiation of human umbilical cord mesenchymal stromal cells in polyglycolic acid scaffolds. Tissue Eng.: Part A 2010;16(6):1937-1948.
123. Cao, H. and N. Kuboyama. A biodegradable porous composite scaffold of PGA/ beta-TCP for bone tissue engineering. Bone 2010;46(2):386-395.
124. Middleton, J. C. and A. J. Tipton. Synthetic biodegradable polymers as orthopedic devices. Biomaterials 2000;21:2335-2346.
125. Wang, S., Y. Zhang, H. Wang, G. Yin, and Z. Dong. Fabrication and properties of the electrospun polylactide/silk fibroin-gelatin composite tubular scaffold. Biomacromolecules 2009;10:2240-2244.
126. Haaparanta, A. M., S. Haimi, V. Ellä, N. Hopper, S. Miettinen, R. Suuronen, and M. Kellomäki. Porous polylactide/beta-tricalcium phosphate composite scaffolds for tissue engineering applications. J. Tissue. Eng. Regen. Med. 2010;4(5):366-373.
127. Miller, R. A., I. M. Brady, and D. E. Cutright. Degradation rates of oral resorbable implants(polylactates and polyglycolates): Rate modification with changes in PLA/PGA copolymer ratios. J. Biomed. Mater. Res. 1977;11:711-719.
128. Bible, E., D. Y. S. Chau, M. R. Alexander, J. Price, K. M. Shakesheff, and M. Modo. The support of neural stem cells transplanted into stroke-induced brain cavities by PLGA particles. Biomaterials 2009;30(16):2985-2994.
129. Yao, L., S. Wang, W. Cui, R. Sherlock, C. O'Connell, G. Damodaran, A. Gorman, A. Windebank, and A. Pandit. Effect of functionalized micropatterned PLGA on guided neurite growth. Acta Biomater. 2009;5:580-588.
130. Ngiam, M., S. Liao, A. J. Patil, Z. Cheng, C. K. Chan, and S. Ramakrishna. The fabrication of nano-hydroxyapatite on PLGA and PLGA/collagen nanofibrous composite scaffolds and their effects in osteoblastic behavior for bone tissue engineering. Bone 2009;45:4-16.
131. Jose, M. V., V. Thomas, K. T. Johnson, D. R. Dean, and E. Nyairo. Aligned PLGA/HA nanofibrous nanocomposite scaffolds for bone tissue engineering. Acta Biomater. 2009;5:305-315.
132. Hu, X., H. Shen, F. Yang, J. Bei, and S. Wang. Preparation and cell affinity of microtubular orientation-structured PLGA(70/30) blood vessel scaffold. Biomaterials 2008;29(21):3128-3136.
133. Garkhal, K., S. Verma, K. Tikoo, and N. Kumar. Surface modified poly(L-lactideco- epsilon-caprolactone) microspheres as scaffold for tissue engineering. J. Biomed. Mater. Res. A 2007;82(3):747-756.
134. Kim, J. H., P. H. Choung, I. Y. Kim, K. T. Lim, H. M. Son, Y. H. Choung, C. S. Cho, and J. H. Chung. Electrospun nanofibers composed of poly(e-caprolactone)and polyethylenimine for tissue engineering applications. Mater. Sci. Eng.: C 2009;29:1725-1731.
135. Guarino, V., F. Causa, P. Taddei, M. D. Foggia, G. Ciapetti, D. Martini, C. Fagnano, N. Baldini, and L. Ambrosio. Polylactic acid fibre-reinforced polycaprolactone scaffolds for bone tissue engineering. Biomaterials 2008;29: 3662-3670.
136. Prior, T. D., D. L. Grace, J. B. MacLean, P. W. Allen, P. G. Chapman, and A. Day. Correction of hallux abductus valgus by Mitchell's metatarsal osteotomy: Comparing standard fixation methods with absorbable polydioxanone pins. Foot 1997;7:121-125.
137. Sokolsky-Papkov, M., K. Agashi, A. Olaye, K. Shakesheff, and A.J. Domb. Polymer carriers for drug delivery in tissue engineering. Adv. Drug Deliv. Rev. 2007;59(4-5):187-206.
138. Jain, J. P., S. Modi, A. J. Domb, and N. Kumar. Role of polyanhydrides as localized drug carriers. J. Control. Release 2005;103:541-563.
139. Jain, J. P., D. Chitkara, and N. Kumar. Polyanhydrides as localized drug delivery carrier: An update. Expert Opin. Drug Deliv. 2008;5(8):889-907.
140. Ibim, S. E. U., M. Attawia, V. R. Shastri, S. F. El-Amin, and R. Bronson. Preliminary in vivo report on the osteocompatibility of poly(anhydride-co-imides) evaluated in a tibial model. J. Biomed. Mater. Res. 1998;43:374-379.
141. Griffin, J., A. Carbone, R. Delgado-Rivera, S. Meiners, and K. E. Uhrich. Design and evaluation of novel polyanhydride blends as nerve guidance conduits. Acta Biomater 2010;6(6):1917-1924.
142. Jain, J. P., S. Modi, and N. Kumar. Hydroxy fatty acid based polyanhydride as drug delivery system: Synthesis, characterization, in vitro degradation, drug release, and biocompatibility. J. Biomed. Mater. Res. A 2008;84:740-752.
143. Modi, S., J. P. Jain, and N. Kumar. Synthesis, characterization, and degradation of poly(ester-anhydride) for particulate delivery. Israel J. Chem. 2005;45: 401-409.
144. Modi, S., J. P. Jain, A. J. Domb, and N. Kumar. Copolymers of pharmaceutical grade lactic acid and sebacic acid: Drug release behavior and biocompatibility. Eur. J. Pharm. Biopharm. 2006;64:277-286.
145. Gunatillake, P. A., and G. F. Meijs. Polyurethanes in biomedical engineering. In Encyclopedia of Materials: Science and Technology: K. H. J. Buschow, R. W. Cahn, M. C. Flemings, B.J. Ilschner, F. J. Kramer, S. Mahajan, and P. Veyssière,(Eds.). Elsevier: Oxford, 2001, pp. 7746-7752.
146. Guelcher, S. A. Biodegradable polyurethanes: Synthesis and applications in regenerative medicine. Tissue Eng.: Part B Rev. 2008;14:3-17.
147. Woźniak, P., M. Bil, J. Ryszkowska, P. Wychowański, E. Wróbel, A. Ratajska, G. Hoser, J. Przybylski, K. J. Kurzydlowski, and M. Lewandowska-Szumiel. Candidate bone-tissue-engineered product based on human-bone-derived cells and polyurethane scaffold. Acta Biomater. 2010;6(7):2484-2493.
148. Li, B., J. M. Davidson, and S. A. Guelcher. The effect of the local delivery of platelet-derived growth factor from reactive two-component polyurethane scaffolds on the healing in rat skin excisional wounds. Biomaterials 2009;30(20): 3486-3494.
149. Shah, P. N., R. L. Manthe, S. T. Lopina, and Y. H. Yun. Electrospinning of l-tyrosine polyurethanes for potential biomedical applications. Polymer 2009; 50(10):2281-2289.
150. Saito, N., T. Okada, H. Horiuchi, H. Ota, J. Takahashi, N. Murakami, M. Nawata, S. Kojima, K. Nozaki, and K. Takaoka. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 2003;32:381-386.
151. Toyoda, H., H. Terai, R. Sasaoka, K. Oda, and K. Takaoka. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Bone 2005;37:555-562.
152. Adelöw, C., T. Segura, J. A. Hubbell, and P. Frey. The effect of enzymatically degradable poly(ethylene glycol) hydrogels on smooth muscle cell phenotype. Biomaterials 2008;29:314-326.
153. Lieb, E., J. Tessmar, M. Hacker, C. Fischbach, D. Rose, T. Blunk, A. G. Mikos, A. Gopferich, and M. B. Schulz. Poly(D,L-lactic acid)-poly(ethylene glycol) monomethyl ether diblock copolymers control adhesion and osteoblastic differentiation of marrow stromal cells. Tissue Eng. 2003;9:71-84.
154. Cui, W., X. Zhu, Y. Yang, X. Li, and Y. Jin. Evaluation of electrospun fibrous scaffolds of poly(DL-lactide) and poly(ethylene glycol) for skin tissue engineering. Mater. Sci. Eng.: C 2009;29:1869-1876.
155. Strehin, I., Z. Nahas, K. Arora, T. Nguyen, and J. Elisseeff. A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel. Biomaterials 2010;31(10):2788-2797.
156. Vashi, A. V., E. Keramidaris, K. M. Abberton, W. A. Morrison, J. L. Wilson, A. J. O'Connor, J. J. Cooper-White, and E. W. Thompson. Adipose differentiation of bone marrow-derived mesenchymal stem cells using Pluronic F-127 hydrogel in vitro. Biomaterials 2008;29:573-579.
157. Ruszymah, B. H., K. Chua, M. A. Latif, F. N. Hussein, and A. B. Saim. Formation of in vivo tissue engineered human hyaline cartilage in the shape of a trachea with internal support. Int. J. Pediatr. Otorhinolaryngol. 2005;69: 1489-1495.
158. Liu, Y., F. Chen, W. Liu, L. Cui, Q. Shang, and W. Xia. Repairing large porcine full-thickness defects of articular cartilage using autologous chondrocyte-engineered cartilage. Tissue Eng. 2002;8:709-721.
159. Cortiella, J., J. E. Nichols, K. Kojima, I. J. Bonassar, P. Dargon, and A. K. Roy. Tissue-engineered lung: An in vivo and in vitro comparison of polyglycolic acid and Pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng. 2006;12:1213-1225.
160. Shachaf, Y., M. Gonen-Wadmany, and D. Seliktar. The biocompatibility of PluronicsF127 fibrinogen-based hydrogels. Biomaterials 2010;31(10):2836-2847.
161. Yaszemski, M. J., R. G. Payne, W. C. Hayes, R. Langer, and A. G. Mikos. In vitro degradation of a poly(propylene fumarate)-based composite materials. Biomaterials 1996;17:2120-2130.
162. Peter, S. J., L. Lu, D. J. Kim, and A. G. Mikos. Marrow stromal osteoblast function on a poly(propylene fumarate)/-tricalcium phosphate biodegradable orthopaedic composite. Biomaterials 2000;21:1207-1213.
163. Temenoff, J. S. and A. G. Mikos. Injectable biodegradable materials for orthopedic tissue engineering. Biomaterials 2000;2:2405-2412.
164. Horch, R. A., N. Shahid, A. S. Mistry, M. D. Timmer, A. G. Mikos, and A. R. Barron. Nanoreinforcement of poly(propylene fumarate)-based networks with surface modified alumoxane nanoparticles for bone tissue engineering. Biomacromolecules 2004;5(5):1990-1998.
165. Jabbari, E., S. F. Wang, L. C. Lu, J. A. Gruetzmacher, S. Ameenuddin, I. E. Hefferan, B. L. Currier, A. J. Windebank, and M. J. Yaszemski. Synthesis, material properties, and biocompatibility of a novel self-cross-linkable poly(caprolactone fumarate) as an injectable tissue engineering scaffold. Biomaterials 2005;6:2503-2511.
166. Payne, R. G., J. S. McGonigle, M. J. Yaszemski, A. W. Yasko, and A. G. Mikos. Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 3. Proliferation and differentiation of encapsulated marrow stromal osteoblasts cultured on crosslinking poly(propylene fumarate). Biomaterials 2002;23:4381-4387.
167. Nicol, F., M. Wong, F. C. MacLaughlin, J. Perrard, E. Wilson, and J. L. Nordstrom. L-glutamate, an anionic polymer, enhances transgene expression for plasmids delivered by intramuscular injection with in vivo electrophoration. Gene Ther. 2002;9:1351-1358.
168. Cai, K., K. Yao, X. Hou, Y. Wang, Y. Hou, Z. Yang, X. Li, and H. Xie. Improvement of the functions of osteoblasts seeded on modified poly(D,L-lactic acid) with poly(aspartic acid). J. Biomed. Mater. Res. 2002;62:283-291.
169. Nojehdehian, H., F. Moztarzadeh, H. Baharvand, H. Nazarian, and M. Tahriri. Preparation and surface characterization of poly-l-lysine-coated PLGA microsphere scaffolds containing retinoic acid for nerve tissue engineering: In vitro study. Colloids Surf. B Biointerf. 2009;73:23-29.
170. Hoffman, R. M. To do tissue culture in two or three dimensions? That is the question. Stem Cells 1993;11(2):105-111.
171. Winter, G. D. and B. J. Simpson. Heterotopic bone formed in a synthetic sponge in the skin of young pigs. Nature 1969;223(5201):88-90.
172. Liebmann-Vinson, A., J. J. Hemperly, R. D. Guarino, C. A. Spargo, and M. A. Heidaran. Bioactive extracellular matrices: Biological and biochemical evaluation. In Tissue Engineering and Biodegradable Equivalents Scientific and Clinical Applications. K. U. Lewandrowski, D. L. Wise, D. J. Trantolo, J. D. Gresser, M. J. Yaszemski, and D. E. Altobelli,(Eds.). Marcel Dekker: New York, 2002.
173. Yates, K. E., F. Allemann, and J. Glowacki. Phenotypic analysis of bovine chondrocytes cultured in 3D collagen sponges: Effect of serum substitutes. Cell Tissue Bank 2005;6(1):45-54.
174. Haider, M., J. Cappello, H. Ghandehari, and K. W. Leong. In vitro chondrogenesis of mesenchymal stem cells in recombinant silk-elastinlike hydrogels. Pharm. Res. 2008;25(3):692-699.
175. Moutos, F. T., L. E. Freed, and F. Guilak. A biomimetic three-dimensional woven composite scaffold for functional tissue engineering of cartilage. Nature Mater. 2007;6:162-167.
176. Gabler, F., S. Frauenschuh, J. Ringe, C. Brochhausen, P. Gotz, C. J. Kirkpatrick, M. Sittinger, H. Schubert, and R. Zehbe. Emulsion-based synthesis of PLGAmicrospheres for the in vitro expansion of porcine chondrocytes. Biomol. Eng. 2007;24(5):515-520.
177. Wahl, D. A., E. Sachlos, C. Liu, and J. T. Czernuszka. Controlling the processing of collagen-hydroxyapatite scaffolds for bone tissue engineering. J. Mater. Sci. Mater. Med. 2007;18(2):201-209.
178. Holmes, T. C. Novel peptide-based biomaterial scaffolds for tissue engineering. Trends Biotechnol. 2002;20(1):16-21.
179. Kim, T. K., J. J. Yoon, D. S. Lee, and T. G. Park. Gas foamed open porous biodegradable polymeric microspheres. Biomaterials 2006;27(2):152-159.
180. Yang, S., K. F. Leong, Z. Du, and C. K. Chua. The design of scaffolds for use in tissue engineering. Part I. Traditional factors. Tissue Eng. 2001;7(6):679-689.
181. Yang, S., K. F. Leong, Z. Du, and C. K. Chua. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng. 2002; 8(1):1-11.
182. Nam, Y. S., J. J. Yoon, and T. J. Park. A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive. J. Biomed. Mater. Res. 2000;53(1):1-7.
183. Hou, Q., D. W. Grijpma, and J. Feijen. Porous polymeric structures for tissue engineering prepared by a coagulation, compression moulding and salt leaching technique. Biomaterials 2003;24(11):1937-1947.
184. Oh, S. H., S. G. Kang, and J. H. Lee. Degradation behavior of hydrophilized PLGA scaffolds prepared by melt-molding particulate-leaching method: comparison with control hydrophobic one. J. Mater. Sci. Mater. Med. 2006; 17(2):131-137.
185. Kim, S. E., J. H. Park, Y. W. Cho, H. Chung, S. Y. Jeong, E. B. Lee, and I. C. Kwon. Porous chitosan scaffold containing microspheres loaded with transforming growth factor-ß1: Implications for cartilage tissue engineering. J. Control. Release 2003;91(3):365-374.
186. Choi, J. S., S. J. Lee, G. J. Christ, A. Atala, and J. J. Yoo. The influence of electrospun aligned poly(varepsilon-caprolactone)/collagen nanofiber meshes on the formation of self-aligned skeletal muscle myotubes. Biomaterials 2008;29(19):2899-2906.
187. Vozzi, G., C. Flaim, A. Ahluwalia, and S. Bhatia. Fabrication of PLGA scaffolds using soft lithography and microsyringe deposition. Biomaterials 2003;24(14): 2533-2540.
188. Hollister, S. J. Porous scaffold design for tissue engineering. Nature Mater. 2005;4:518-524.
189. Williams, J. M., A. Adewunmi, R. M. Schek, C. L. Flanagan, P. H. Krebsbach, S. E. Feinberg, S. J. Hollister, and S. Das. Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials 2005;26(23):4817-4827.
190. Moroni, L. and C. A. V. Blitterswijk. Converge and regenerate. Nature Mater. 2006;5:437-438.
191. Sun, W., B. Starly, A. Darling, and C. Gomez. Computer-aided tissue engineering: Application to biomimetic modelling and design of tissue scaffolds. Biotech. Appl. Biochem. 2004;39(Pt 1):49-58.
192. Yancopoulos, G. D., S. Davis, N. W. Gale, J. S. Rudge, S. J. Wiegand, and J. Holash. Vascular-specific growth factors and blood vessel formation. Nature 2000;407(6801):242-248.
193. Babensee, J. E., L. V. McIntire, and A. G. Mikos. Growth factor delivery for tissue engineering. Pharm. Res. 2000;17(5):497-504.
194. Richardson, T. P., M. C. Peters, A. B. Ennett, and D. J. Mooney. Polymeric system for dual growth factor delivery. Nature Biotechnol. 2001;19(11):1029-1034.
195. Shea, L. D., E. Smiley, J. Bonadio, and D. J. Mooney. DNA delivery from polymer matrices for tissue engineering. Nature Biotechnol. 1999;17(6):551-554.
196. Putnam, D. Polymers for gene delivery across length scales. Nature Mater. 2006; 5(6):439-451.
197. Guimard, N. K., N. Gomez, and C. E. Schmidt. Conducting polymers in biomedical engineering. Prog. Polym. Sci. 2007;32(8-9):876-921.
198. Gong, F., X. Cheng, S. Wang, Y. Zhao, Y. Gao, and H. Cai. Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents. Acta Biomater. 2010;6(2):534-546.
199. Friend, J. R. and W.-S. Hu. Engineering a bioartificial liver support. Frontiers Tissue Eng. 1998;678-695.
200. Mayer, J., E. Karamuk, T. Akaike, and E. Wintermantel. Matrices for tissue engineering-scaffold structure for a bioartificial liver support system. J. Control. Release 2000;64(1-3):81-90.
201. Stamatialis, D. F., B. J. Papenburg, M. Gironés, S. Saiful, S. N. M. Bettahalli, S. Schmitmeier, and M. Wessling. Medical applications of membranes: Drug delivery, artificial organs and tissue engineering. J. Memb. Sci. 2008;308(1-2):1-34.
202. Nieminen, T., I. Kallela, J. Keränen, I. Hiidenheimo, H. Kainulainen, E. Wuolijoki, and I. Rantala. In vivo and in vitro degradation of a novel bioactive guided tissue regeneration membrane. Int. J. Oral. Maxillofacial. Surg. 2006;35(8):727-732.
203. Lu, Q., A. Simionescu, and N. Vyavahare. Novel capillary channel fiber scaffolds for guided tissue engineering. Acta Biomater. 2005;1(6):607-614.
204. Wan, Y., H. Wu, B. Xiao, X. Cao, and S. Dalai. Chitosan-g-polycaprolactone copolymer fibrous mesh scaffolds and their related properties. Polym. Adv. Technol. 2009;20:795-801.
205. Kumbar, S. G., S. P. Nukavarapu, R. James, I. S. Nair, and C. T. Laurencin. Electrospun poly(lactic acid-co-glycolic acid) scaffolds for skin tissue engineering. Biomaterials 2008;29(30):4100-4107.
206. Ghalbzouri, A. E., E. N. Lamme, C. V. Blitterswijk, J. Koopman, and M. Ponec. The use of PEGT/PBT as a dermal scaffold for skin tissue engineering. Biomaterials 2004;25:2987-2996.
207. Harrison, C. A. and S. MacNeil. The mechanism of skin graft contraction: An update on current research and potential future therapies. Burns 2008; 34(2):153-163.
208. MacNeil, S. Biomaterials for tissue engineering of skin. Materialstoday 2008;11:26-35.
209. Stevens, M. M. Biomateials for bone tissue engineering. Materialstoday 2008;11:18-25.
210. Hedberg, E. L., A. Tang, R. S. Crowther, D. H. Carney, and A. G. Mikos. Controlled release of an osteogenic peptide from injectable biodegradable polymeric composites. J. Control. Release 2009;84(3):137-150.
211. Arrington, E. D., W. J. Smith, H. G. Chambers, A. L. Bucknell, and N. A. Davino. Complications of iliac crest bone graft harvesting. Clin. Orthop. Relat. Res. 1996;329:300-309.
212. Lee, S. H. and H. Shin. Matrices and scaffolds for delivery of bioactive molecules in bone and cartilage tissue engineering. Adv. Drug Deliv. Rev. 2007;59(4-5) :339-359.
213. Silva, G. A., O. P. Coutinho, P. Ducheyne, and R. L. Reis. Materials in particulate form for tissue engineering. 2. Applications in bone. J. Tissue Eng. Regen. Med. 2007;1:97-109.
214. Zhang, Y., B. Shi, C. Li, Y. Wang, Y. Chen, W. Zhang, T. Luo, and X. Cheng. The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chitosan/collagen scaffolds. J. Control. Release 2009;136(3):172-178.
215. Porter, J.R., A. Henson, and K. C. Popat. Biodegradable poly(epsilon-caprolactone) nanowires for bone tissue engineering applications. Biomaterials 2009;30(5): 780-788.
216. Shi, X., Y. Wang, L. Ren, W. Huang, and D. A. Wang. A protein/antibiotic releasing poly(lactic-co-glycolic acid)/lecithin scaffold for bone repair applications. Int. J. Pharm. 2009;373(1-2):85-92.
217. Moioli, E. K., P. A. Clark, X. Xin, S. Lal, and J. J. Mao. Matrices and scaffolds for drug delivery in dental, oral and craniofacial tissue engineering. Adv. Drug Deliv. Rev. 2007;59(4-5):308-324.
218. Kaigler, D., J. A. Cirelli, and W. V. Giannobile. Growth factor delivery for oral and periodontal tissue engineering. Expert Opin. Drug Deliv. 2006;3:647-662.
219. Puppi, D., F. Chiellini, A. M. Piras, and E. Chiellini. Polymeric materials for bone and cartilage repair. Prog. Polym. Sci. 2008;33(12):1119-1198.
220. Smith, A. J. and P. T. Sharpe. Biological tooth replacement and repair. In Principles of Tissue Engineering, 3rd ed.: R. Lanza, R. Langer, and J. Vacanti,(Eds.). Academic Press: Burlington, 2007, pp. 1067-1077.
221. Young, S., K. A. Athanasiou, A. G. Mikos, and ME.-K. Wong. Oral and maxillofacial surgery. In Principles of Tissue Engineering, 3rd ed. R. Lanza, R. Langer, and J. Vacanti,(Eds.). Academic Press: Burlington, 2007, pp. 1079-1094.
222. Zhang, H., H. K. Fong, W. V. Giannobile, and M. J. Somerman. Periodontal tissue engineering. In Principles of Tissue Engineering, 3rd ed. R. Lanza, R. Langer, J. Vacanti,(Eds.). Academic Press: Burlington, 2007, pp. 1095-1109.
223. Edwards, P. C. and J. M. Mason. Gene-enhanced tissue engineering for dental hard tissue regeneration:(2) Dentin-pulp and periodontal regeneration. Head Face Med. 2006;2:16.
224. Edwards, P. C. and J. M. Mason. Gene-enhanced tissue engineering for dental hard tissue regeneration:(1) Overview and practical considerations. Head Face Med. 2006;2:12.
225. Chung, C. and J. A. Burdick. Engineering cartilage tissue. Adv. Drug Deliv. Rev. 2008;60:243-262.
226. Nesic, D. R. Whiteside, M. Brittberg, D. Wendt, I. Martin, and P. Mainil-Varlet. Cartilage tissue engineering for degenerative joint disease. Adv. Drug Deliv. Rev. 2006;58:300-322.
227. Husing, B., B. Bührlen, and S. Gaisser. Human Tissue Engineered Products- Today's Markets and Future Prospects. Fraunhofer Institute for Systems and Innovation Research: Karlsruhe, Germany, pp. 1-129.
228. Elisseeff, J., W. McIntosh, K. Fu, T. Blunk, and R. Langer. Controlled-release of IGF-I and TGF-P 1 in a photopolymerizing hydrogel for cartilage tissue engineering. J. Orthop. Res. 2001;19:1098-1104.
229. Hedberg, E. L., C. L. Shih, L. A. Solchaga, A. I. Caplan, and A. G. Mikos. Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers. J. Control. Release 2004;100:257-266.
230. Aigner,T., A. Sachse,P.M. Gebhard, andH. I. Roach. Osteoarthritis:Pathobiology- targets and ways for therapeutic intervention. Adv. Drug Deliv. Rev. 2006;58: 128-149.
231. Aigner, T. and J. Stove. Collagen-major component of the physiological cartilage matrix, major target of cartilage degeneration, major tools in cartilage repair. Adv. Drug Deliv. Rev. 2003;55:1569-1593.
232. Sales, K. M., H. J. Salacinski, N. Alobaid, M. Mikhail, V. Balakrishnan, and A. M. Seifalian. Advancing vascular tissue engineering: The role of stem cell technology. Trends Biotechnol. 2005;23:461-467.
233. Leora, J., Y. Amsalema, and S. Cohen. Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol. Therap. 2005;105:151-163.
234. Masuda, S., T. Shimizu, M. Yamato, and T. Okano. Cell sheet engineering for heart tissue repair. Adv. Drug Deliv. Rev. 2008;60:277-285.
235. Wu, K. H., X. M. Moa, Y. L. Liu, Y. S. Zhang, and Z. C. Han. Stem cells for tissue engineering of myocardial constructs. Ageing Res. Rev. 2007;6:289-301.
236. Cao, H., T. Liu, and S. Y. Chew. The application of nanofibrous scaffolds in neural tissue engineering. Adv. Drug Deliv. Rev. 2009;61(12):1055-1064.
237. Willerth, S. M. and S. E. Sakiyama-Elbert. Approaches to neural tissue engineering using scaffolds for drug delivery. Adv. Drug Deliv. Rev. 2007;59(4-5):325-338.
238. Humes, H. D., S. M. MacKay, A. J. Funke, and D. A. Buffington. Tissue engineering of a bioartificial renal tubule assist device: In vitro transport and metabolic characteristics. Kidney Int. 1999;55:2502-2514.
239. Bianco, P. and P. G. Robey. Stem cells in tissue engineering. Nature 2001;414:118-121.
240. Furth, M. E., A. Atala, and M. E. V. Dyke. Smart biomaterials design for tissue engineering and regenerative medicine. Biomaterials 2007;28:5068-5073.
241. Zhao, X. and S. Zhang. Fabrication of molecular materials using peptide construction motifs. Trends Biotechnol. 2004;22(9):470-476.
242. Guler, M. O., L. Hsu, S. Soukasene, D. A. Harrington, J. F. Hulvat, and S. I. Stupp. Presentation of RGDS epitopes on self-assembled nanofibers of branched peptide amphiphiles. Biomacromolecules 2006;7(6):1855-1863.
243. Hartgerink, J. D., E. Beniash, and S. I. Stupp. Peptide-amphiphile nanofibers: A versatile scaffold for the preparation of self-assembling materials. Proc. Natl. Acad. Sci. U.S.A. 2002;99(8):5133-5138.
244. Chan, G. and D. J. Mooney. New materials for tissue engineering: Towards greater control over the biological response. Trends Biotechnol. 2008;26(7):382-392.
245. Wang, D. A., S. Varghese, B. Sharma, I. Strehin, S. Fermanian, J. Gorham, D. H. Fairbrother, B. Cascio, and J. H. Elisseeff. Multifunctional chondroitin sulphate for cartilage tissue-biomaterial integration. Nature Mater 2007;6(5):385-392.
246. Mooney, D. J. and E. A. Silva. A glue for biomaterials. Nature Mater. 2007;6:327-328.
247. Heidaran, M. A. Tissue engineering: A biological solution for tissue damage, loss or end stage organ failure. Iran. Biomed. J. 2000;4:1-5.